Benzinga

España
Italia
대한민국
日本
Français
Benzinga Edge
Benzinga Research
Benzinga Pro

  • Get Benzinga Pro
  • Data & APIs
  • Events
  • Premarket
  • Advertise
Contribute
España
Italia
대한민국
日本
Français

Benzinga

  • Premium Services
  • Financial News
    Latest
    Earnings
    Guidance
    Dividends
    M&A
    Buybacks
    Interviews
    Management
    Offerings
    IPOs
    Insider Trades
    Biotech/FDA
    Politics
    Healthcare
    Small-Cap
  • Markets
    Pre-Market
    After Hours
    Movers
    ETFs
    Options
    Cryptocurrency
    Commodities
    Bonds
    Futures
    Mining
    Real Estate
    Volatility
  • Ratings
    Analyst Color
    Downgrades
    Upgrades
    Initiations
    Price Target
  • Investing Ideas
    Trade Ideas
    Long Ideas
    Short Ideas
    Technicals
    Analyst Ratings
    Analyst Color
    Latest Rumors
    Whisper Index
    Stock of the Day
    Best Stocks & ETFs
    Best Penny Stocks
    Best S&P 500 ETFs
    Best Swing Trade Stocks
    Best Blue Chip Stocks
    Best High-Volume Penny Stocks
    Best Small Cap ETFs
    Best Stocks to Day Trade
    Best REITs
  • Money
    Investing
    Cryptocurrency
    Mortgage
    Insurance
    Yield
    Personal Finance
    Forex
    Startup Investing
    Real Estate Investing
    Prop Trading
    Credit Cards
    Stock Brokers
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
Unusual Options Activity Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Screeners
Stock Screener
Top Momentum Stocks
Top Quality Stocks
Top Value Stocks
Top Growth Stocks
Compare Best Stocks
Best Momentum Stocks
Best Quality Stocks
Best Value Stocks
Best Growth Stocks
Connect With Us
facebookinstagramlinkedintwitteryoutubeblueskymastodon
About Benzinga
  • About Us
  • Careers
  • Advertise
  • Contact Us
Market Resources
  • Advanced Stock Screener Tools
  • Options Trading Chain Analysis
  • Comprehensive Earnings Calendar
  • Dividend Investor Calendar and Alerts
  • Economic Calendar and Market Events
  • IPO Calendar and New Listings
  • Market Outlook and Analysis
  • Wall Street Analyst Ratings and Targets
Trading Tools & Education
  • Benzinga Pro Trading Platform
  • Options Trading Strategies and News
  • Stock Market Trading Ideas and Analysis
  • Technical Analysis Charts and Indicators
  • Fundamental Analysis and Valuation
  • Day Trading Guides and Strategies
  • Live Investor Events
  • Pre-market Stock Analysis and News
  • Cryptocurrency Market Analysis and News
Ring the Bell

A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.

  • Terms & Conditions
  • Do Not Sell My Personal Data/Privacy Policy
  • Disclaimer
  • Service Status
  • Sitemap
© 2026 Benzinga | All Rights Reserved
October 21, 2024 1:54 PM 2 min read

What's Going On With Kenvue Stock Monday?

by Dylan Berman
Follow

Kenvue Inc. (NYSE:KVUE) shares are moving higher Monday following a report suggesting activist investor Starboard Value has acquired a stake in the company.

The Details: According to the Wall Street Journal, Starboard has acquired a “sizable” stake in Kenvue and is pushing for changes to boost the consumer-products company’s share price. The activist investor asserts that Kenvue has “some of the best consumer brands,” yet its stock has lagged behind its competitors for over a year.

Kenvue’s iconic brands include Aveeno, BAND-AID Brand, Johnson’s, Listerine, Neutrogena and Tylenol. Kenvue shares are up just 7% year-to-date compared to more than 23% gains in the S&P 500. Competitors Haleon (NYSE:HLN) and Proctor and Gamble Company (NYSE:PG) have climbed 21% and 16%, respectively, since the start of the year.

The exact size of Starboard's position in Kenvue was not shared. Starboard’s specific turnaround ideas were also not reported, but people familiar with the matter said Starboard CEO Jeff Smith is expected to discuss more about Starboard’s perspective on Kenvue at the 13D Monitor Active-Passive Investor Summit in New York on Tuesday.

According to a separate report, Starboard may try to push the company to sell its skin, healthcare and beauty division in whole or part.

In a note released Monday, JPMorgan analyst Andrea Teixeira said, “Given the SHB segment has been a key area of debate on the stock over the past year and a half, we would expect Starboard to detail changes it would like to see management make to this division — which we suspect could involve divesting some/all of the segment.”

Kenvue was spun out of Johnson & Johnson (NYSE:JNJ) last year. The company currently has a market cap of more than $41 billion, according to data from Benzinga Pro.

Related Link: Elon Musk, Tesla Refute Inefficiency Concerns With Wireless Charging On Cybercab: ‘There Is No Meaningful Efficiency Difference…’

KVUE Price Action: At the time of publication, Kenvue stock was up 5.96% at $23.02, according to data from Benzinga Pro.

Image: 3972315 from Pixabay.

Market News and Data brought to you by Benzinga APIs

© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

To add Benzinga News as your preferred source on Google, click here.


Posted In:
NewsMoverswhy it's moving
KVUE Logo
KVUEKenvue Inc
$18.65-0.27%
Overview
HLN Logo
HLNHaleon PLC
$11.20-%
JNJ Logo
JNJJohnson & Johnson
$244.720.52%
PG Logo
PGProcter & Gamble Co
$160.100.02%
KVUE Logo
KVUEKenvue Inc
$18.65-0.27%
Overview
HLN Logo
HLNHaleon PLC
$11.20-%
JNJ Logo
JNJJohnson & Johnson
$244.720.52%
PG Logo
PGProcter & Gamble Co
$160.100.02%
Comments
Loading...